Dualantiplatelettherapy相关论文
Duration of Dual Antiplatelet Therapyafter Implantation of the first-and second-generation Drug-Elut
...
Efficacy of Dual Antiplatelet Therapy Combined with Naoxintong Capsules(脑心通胶囊) Following Coronary Mi
Objective: To evaluate the efficacy of dual antiplatelet therapy combined with Naoxintong Capsule (脑心通胶囊, NXTC) in ......
...
Clinical Impact of Dual Antiplatelet Therapy Use in Patients Following Everolimus-eluting Stent Impl
...
Shorter- versus Longer-duration Dual Antiplatelet Therapy in Patients with Diabetes Mellitus Undergo
...
Efficacy and safety of triple-antiplatelet therapy after percutaneous coronary intervention: a meta-
...
Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Ste
Percutaneous coronary intervention (PCI) with implantation of drug-eluting stents (DESs) has become the standard of care......
Clinical Impact of Dual Antiplatelet Therapy Use in Patients Following Everolimus-eluting Stent Impl
Background: Studies have suggested that use of prolonged dual antiplatelet therapy (DAPT) following new generation d......
目的:系统评价药物洗脱支架(DES)置入后≤6个月与≥12个月双联抗血小板治疗(DAPT)的安全性和有效性。方法:收集2015-01之前公布随......
阿司匹林联合P2Y 12受体抑制剂（氯吡格雷、普拉格雷或替格瑞洛）的双联抗血小板治疗是急性冠状动脉综合征的基础治疗。与氯吡格雷相比......
经皮冠状动脉药物洗脱支架植入术后有两种常见的并发症，一是支架内血栓形成，二是支架内再狭窄。降低这两种并发症发生率的重要方法是......
双重抗血小板治疗是将P2Y12受体拮抗剂(氯吡格雷、普拉格雷或替格瑞洛)与阿司匹林联合使用.该疗法的治疗对象主要是在过去12个月内......
